Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy
Author:
Funder
InoMed project
Czech Science Foundation
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference150 articles.
1. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer;Abdel-Fatah;Molecular Oncology,2015
2. Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan;Abu-Sanad;Frontiers in Pharmacology,2015
3. Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy;Al-Ahmadie;Cancer Discovery,2014
4. Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy;Al-Subhi;Breast Cancer Research and Treatment,2018
5. Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer;Alsubhi;Molecular Oncology,2016
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance;Drug Resistance Updates;2024-03
2. Design, synthesis, and biological characterization of proteolysis targeting chimera (PROTACs) for the ataxia telangiectasia and RAD3-related (ATR) kinase;European Journal of Medicinal Chemistry;2024-03
3. Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500);Journal of Medicinal Chemistry;2024-02-01
4. Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets;International Journal of Molecular Sciences;2024-01-19
5. Signaling mechanisms of chemoresistance in breast cancer stem cells for therapeutics;Cancer Stem Cells and Signaling Pathways;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3